随机临床试验:心理干预通过减轻腹痛和疲劳改善克罗恩病患者的工作效率和日常活动
这项多中心平行组随机对照试验的二次分析纳入142例轻中度克罗恩病患者,比较COBMINDEX(认知行为与正念干预)与常规治疗3个月的效果。完成数据收集的120例患者中,干预组腹痛、疲劳、工作受损和日常活动受损均显著低于对照组,且腹痛和疲劳的变化介导了COBMINDEX对工作生产力和日常活动的改善作用。
要点
- COBMINDEX可显著降低克罗恩病患者的腹痛和疲劳。
- 腹痛和疲劳的改善介导了工作效率和日常活动的提升。
- 作者建议临床医生筛查严重腹痛和疲劳,并考虑提供认知行为与正念训练。
核心结论
- COBMINDEX能有效减轻克罗恩病患者的腹痛和疲劳,进而改善功能。
- 作者建议临床医生纳入严重腹痛和疲劳的筛查,并考虑提供认知行为与正念训练。
研究设计与样本
- 多中心平行组随机对照试验的二次分析。
- 142例轻中度克罗恩病患者随机分为干预组(接受COBMINDEX)或对照组(先接受常规治疗3个月后接受COBMINDEX)。
- 完成数据收集的120例患者(34.0±10.7岁,62.5%女性,干预组=60,对照组=60)纳入分析。
- 采用协方差分析比较3个月随访评分(控制基线评分),并对全样本进行多重平行中介分析。
主要发现
- 干预组腹痛显著低于对照组(F=17.46,p<0.001,η2p=0.13)。
- 干预组疲劳显著低于对照组(F=7.26,p=0.008,η2p=0.06)。
- 干预组工作受损显著低于对照组(F=4.82,p=0.032,η2p=0.07)。
- 干预组日常活动受损显著低于对照组(F=6.26,p=0.014,η2p=0.05)。
- 腹痛和疲劳的变化显著介导了COBMINDEX对工作效率(b=-9.90,SE=2.86,95%CI:-16.11至-4.94)和日常活动(b=-9.65,SE=1.91,95%CI:-13.77至6.35)的改善作用,且独立于疾病活动度变化。
临床怎么用
- 作者建议临床医生纳入严重腹痛和疲劳的筛查。
- 作者建议考虑提供认知行为与正念训练。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic abdominal pain and fatigue are characteristics of Crohn's disease (CD) and contribute to functional impairments. AIMS: To examine whether CD-tailored cognitive-behavioural and mindfulness intervention (COBMINDEX) is effective in reducing abdominal pain and fatigue in patients with CD and whether changes in abdominal pain and fatigue mediate any beneficial effects of COBMINDEX on impairments in work productivity and daily activities. METHODS: This is a secondary analysis of a parallel-group multicentre randomised controlled trial. Patients with mild-to-moderate CD (n = 142) were randomised into either intervention group receiving COBMINDEX, or control group receiving treatment-as-usual for 3 months followed by COBMINDEX. Complete data were collected from 120 patients (34.0 ± 10.7 years, 62.5% female, intervention = 60, control = 60). Analysis of covariance assessed group differences in 3-month follow-up scores, controlling for baseline scores. Multiple parallel mediation analysis assessed the proposed mechanisms for the entire sample. RESULTS: The intervention group demonstrated significantly lower levels of abdominal pain (F = 17.46, p < 0.001, η2 p = 0.13), fatigue (F = 7.26, p = 0.008, η2 p = 0.06) and impairments at work (F = 4.82, p = 0.032, η2 p = 0.07) and daily activities (F = 6.26, p = 0.014, η2 p = 0.05), compared with treatment-as-usual. Moreover, changes in abdominal pain and fatigue significantly mediated the beneficial effects of COBMINDEX on patients' work productivity (b = -9.90, SE = 2.86, 95% CI: -16.11 to -4.94) and daily activities (b = -9.65, SE = 1.91, 95% CI: -13.77 to 6.35), independent of changes in disease activity. CONCLUSIONS: COBMINDEX is effective at reducing abdominal pain and fatigue in patients with CD, which in turn leads to improvement in functioning. Clinicians should incorporate screening for severe abdominal pain and fatigue and consider offering cognitive-behavioural and mindfulness training. CLINICALTRIALS: gov, Number: NCT05085925. Ministry of Health in Israel (https://my.health.gov.il/CliniTrials/Pages/MOH_2020-02-24_008721.aspx).
引用
- Regev S, Schwartz D, Sarid O, et al. Randomised clinical trial: Psychological intervention improves work productivity and daily activity by reducing abdominal pain and fatigue in Crohn's disease. Aliment Pharmacol Ther. 2023. PMID: 36734040. doi:10.1111/apt.17399
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。